Prophylactic medication for the prevention of endoscopic recurrence in Crohn's disease: a prospective study based on clinical risk stratification.

Jeanine H C Arkenbosch Evelien M J BeelenGerard DijkstraMariëlle Romberg-CampsMarjolijn DuijvesteinFrank HoentjenSander van der MarelP W Jeroen MaljaarsSita JansenNanne K H de BoerRachel L WestCarmen S HorjusLaurents P S StassenFiona D M van SchaikOddeke van RulerBindia J H JharapMarijn VisschedijkAlfred JanssenNicole S ErlerMichael DoukasAriadne H A G OomsGursah Kats-UgurluC Janneke van der WoudeAnnemarie C de Vriesnull null

Published in: Journal of Crohn's & colitis (2022)

Adherence to this management algorithm is 65%. Prophylactic medication after ICR prevents endoscopic recurrence in low and high-risk patients. Clinical risk stratification has an acceptable predictive value, but further refinement is needed.

Keyphrases

end stage renal disease
ultrasound guided
newly diagnosed
healthcare
ejection fraction
chronic kidney disease
machine learning
free survival
emergency department
adverse drug
mouse model
adipose tissue
patient reported outcomes
skeletal muscle
insulin resistance
glycemic control